Department of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Department of Biochemistry, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, Brazil.
J Psychiatr Res. 2018 May;100:16-23. doi: 10.1016/j.jpsychires.2018.02.006. Epub 2018 Feb 13.
Some studies have demonstrated that ascorbic acid, similarly to ketamine, exhibits antidepressant-like effects mediated, at least in part, by modulation of the glutamatergic system. Despite the involvement of glutamatergic system in the pathophysiology of anxiety disorders, the ability of ascorbic acid and ketamine to elicit anxiolytic effects in animal models remains to be established. Therefore, this study investigated the effects of a single administration of ascorbic acid, ketamine or diazepam (positive control) in different animal models of anxiety. Mice were treated with ascorbic acid (1, 3 and 10 mg∕kg, p.o.), ketamine (1 and 10 mg∕kg, i.p.) or diazepam (2 mg∕kg, p.o) and their behavioral responses were assessed in the elevated plus maze, open field test (OFT), ligh∕dark preference test and marble burying test. Ascorbic acid increased total time spent in the open arms of elevated plus maze, increased total time in the center of the OFT, decreased rearing responses, increased the latency to grooming, decreased the rostral grooming, but did not affect body grooming. Furthermore, ascorbic acid increased the latency time and total time in light area in the ligh∕dark preference test, but did not affect the performance of mice in the marble burying test. Ketamine demonstrated an anxiolytic-like effect in elevated plus maze, OFT, and ligh∕dark preference test. Diazepam exhibited an anxiolytic-like effect in all the behavioral tests. Altogether, the results indicate the potential anxiolytic effect of ascorbic acid and ketamine, providing a possible new avenue for the management of anxiety-related disorders.
一些研究表明,抗坏血酸与氯胺酮类似,具有抗抑郁作用,至少部分是通过调节谷氨酸能系统介导的。尽管谷氨酸能系统参与了焦虑障碍的病理生理学,但抗坏血酸和氯胺酮在动物模型中产生抗焦虑作用的能力仍有待确定。因此,本研究调查了单次给予抗坏血酸、氯胺酮或地西泮(阳性对照)在不同焦虑动物模型中的作用。用抗坏血酸(1、3 和 10mg∕kg,口服)、氯胺酮(1 和 10mg∕kg,腹腔注射)或地西泮(2mg∕kg,口服)处理小鼠,然后在高架十字迷宫、旷场试验(OFT)、明暗偏好试验和大理石掩埋试验中评估其行为反应。抗坏血酸增加了高架十字迷宫开臂的总停留时间,增加了 OFT 中心的总停留时间,减少了竖立反应,增加了梳理潜伏期,减少了头部梳理,但不影响身体梳理。此外,抗坏血酸增加了明暗偏好试验中光照区域的潜伏期和总时间,但不影响小鼠在大理石掩埋试验中的表现。氯胺酮在高架十字迷宫、OFT 和明暗偏好试验中表现出抗焦虑样作用。地西泮在所有行为测试中均表现出抗焦虑样作用。总之,这些结果表明抗坏血酸和氯胺酮具有潜在的抗焦虑作用,为焦虑相关障碍的治疗提供了一种新的可能途径。